0001209191-16-148718.txt : 20161107
0001209191-16-148718.hdr.sgml : 20161107
20161107183832
ACCESSION NUMBER: 0001209191-16-148718
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161103
FILED AS OF DATE: 20161107
DATE AS OF CHANGE: 20161107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 MILK STREET
STREET 2: 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 50 MILK STREET
STREET 2: 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mattsson Jan
CENTRAL INDEX KEY: 0001687436
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 161979527
MAIL ADDRESS:
STREET 1: C/O ALBIREO PHARMA, INC.
STREET 2: 50 MILK STREET, 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-03
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001687436
Mattsson Jan
C/O ALBIREO PHARMA INC.
50 MILK STREET, 16TH FLOOR
BOSTON
MA
02109
0
1
0
0
Chief Operating Officer
Common Stock
2016-11-03
4
A
0
59214
0.00
A
59214
D
Stock Option (right to buy)
1.00
2016-11-03
4
A
0
39330
0.00
A
2021-03-18
Common Stock
39330
39330
D
Represents shares of common stock of Albireo Pharma, Inc. (the "Issuer"), formerly known as Biodel Inc., issued in the share exchange transaction that was completed on November 3, 2016 pursuant to an Amended and Restated Share Exchange Agreement, dated as of July 13, 2016, by and among Biodel Inc., Albireo Limited ("Albireo") and the holders of Albireo shares and notes convertible into Albireo shares.
This option was issued in replacement of a warrant to purchase shares of Albireo Limited.
This option vests and becomes exercisable as to 33.33% of the underlying shares on the grant date and the remainder in 32 equal installments on the first day of each calendar month beginning with December 1, 2016 and ending July 1, 2019.
/s/ Peter A. Zorn, Attorney-in-fact
2016-11-07